CM
KRTX

Caption Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Caption Management’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-102,100
Closed -$32.3M – 1774
2023
Q4 		$32.3M Buy
102,100
+92,100
+921% +$17.9M 0.44% 39
2023
Q3 		$1.69M Sell
10,000
-144,500
-94% -$27.2M 0.03% 629
2023
Q2 		$33.5M Sell
154,500
-45,500
-23% -$9.75M 0.59% 20
2023
Q1 		$36.3M Buy
200,000
+190,000
+1,900% +$36.3M 0.7% 23
2022
Q4 		$1.97M Hold
10,000
– – 0.03% 566
2022
Q3 		$2.25M Sell
10,000
-5,000
-33% -$1.01M 0.03% 598
2022
Q2 		$1.9M Buy
+15,000
New +$1.72M 0.03% 683
2021
Q4 		– Sell
-6,400
Closed -$783K – 2025
2021
Q3 		$783K Sell
6,400
-8,600
-57% -$993K 0.01% 1095
2021
Q2 		$1.71M Buy
+15,000
New +$1.75M 0.02% 728

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Caption Management's KRTX Position: Q4 2023 in Review

Caption Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q4 2023, closing a stake of 7,900 shares — an estimated $1.54M sold.

Caption Management first reported a position in KRTX in Q3 2021 and held it in 4 quarters. The position peaked at $1.34M in Q3 2023. 328 funds tracked by Wall St. Rank hold KRTX as of Q4 2023.

  • Caption Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Caption Management sold 7,900 Karuna Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $1.54M.
  • Caption Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q3 2021 and held it in 4 quarters.
  • Caption Management's Karuna Therapeutics, Inc. Common Stock position peaked at $1.34M in Q3 2023.
  • 328 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q4 2023.

Based on Caption Management's 13F filing for Q4 2023, filed 14 Feb 2024.